Related Experiment Video
Updated: May 7, 2026

06:44
Modeling Brain Metastases Through Intracranial Injection and Magnetic Resonance Imaging
Published on: June 7, 2020
7.2K
Deep Learning for Synthetic Postcontrast T1-Weighted MRI: A Systematic Review With Targeted Meta-Analysis of Brain
Siddhant Dogra1, Emmy Hu1, Stella K Kang2
1Department of Radiology, NYU Grossman School of Medicine, New York, NY.
AJR. American Journal of Roentgenology
|May 6, 2026
Summary
Deep learning (DL) can synthesize postcontrast MRI from precontrast scans, reducing gadolinium risks. However, significant heterogeneity in study design and limited clinical validation hinder its widespread adoption in medical imaging.
Area of Science:
- Radiology and Medical Imaging
- Artificial Intelligence in Healthcare
- Deep Learning Applications
Background:
- Gadolinium-based contrast agents are crucial for MRI but pose risks.
- Deep learning (DL) offers a promising method to synthesize postcontrast T1-weighted MRI from precontrast sequences alone.
Purpose of the Study:
- To systematically review DL-based synthesis of postcontrast T1-weighted MRI.
- To characterize DL model architectures and evaluation practices across subspecialties.
- To perform meta-analysis on brain tumor studies using DL for image synthesis.
Main Methods:
- Systematic literature search across major databases (PubMed, Embase, etc.) up to January 2025.
- Independent screening and data extraction by two reviewers on study characteristics, metrics, and reader studies.
- Risk of bias assessment using modified QUADAS-2 and random-effects meta-analysis for brain tumor studies.
Main Results:
- 41 studies met inclusion criteria, predominantly in neuroimaging (59%).
- Generative adversarial networks and convolutional neural networks were common architectures.
- High heterogeneity (I² > 99%) was observed, with pooled SSIM of 0.92 and PSNR of 30.6 dB for brain tumors.
- Pathology-specific evaluation showed lower metrics; only 37% included reader studies.
Conclusions:
- DL-based postcontrast MRI synthesis is technically feasible but faces challenges.
- Substantial heterogeneity in study design and inconsistent evaluation metrics limit clinical translation.
- Standardized evaluation, including reader studies and external validation, is crucial for clinical adoption.

